These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 18682813
1. Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy. Petrovic MG, Korosec P, Kosnik M, Osredkar J, Hawlina M, Peterlin B, Petrovic D. Mol Vis; 2008 Jul 30; 14():1382-7. PubMed ID: 18682813 [Abstract] [Full Text] [Related]
2. Relationship of vascular endothelial growth factor (VEGF) +405 G/C polymorphism and proliferative retinopathy in patients with type 2 diabetes. Feghhi M, Nikzamir A, Esteghamati A, Mahmoudi T, Yekaninejad MS. Transl Res; 2011 Aug 30; 158(2):85-91. PubMed ID: 21757152 [Abstract] [Full Text] [Related]
3. Vascular endothelial growth factor (VEGF)-related polymorphisms rs10738760 and rs6921438 are not risk factors for proliferative diabetic retinopathy (PDR) in patients with type 2 diabetes mellitus (T2DM). Sajovic J, Cilenšek I, Mankoč S, Tajnšek Š, Kunej T, Petrovič D, Globočnik Petrovič M. Bosn J Basic Med Sci; 2019 Feb 12; 19(1):94-100. PubMed ID: 30579324 [Abstract] [Full Text] [Related]
8. A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, Inoue I, Katayama S. Diabetes; 2002 May 12; 51(5):1635-9. PubMed ID: 11978667 [Abstract] [Full Text] [Related]
11. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy. Wang X, Wang G, Wang Y. Am J Ophthalmol; 2009 Dec 12; 148(6):883-9. PubMed ID: 19837381 [Abstract] [Full Text] [Related]
12. Serum and vitreous vascular endothelial growth factor levels in diabetic retinopathy. Sozen-Delil FI, Cekic O, Haklar G. Int Ophthalmol; 2023 Jul 12; 43(7):2247-2255. PubMed ID: 36580154 [Abstract] [Full Text] [Related]
13. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy. Burgos R, Simó R, Audí L, Mateo C, Mesa J, García-Ramírez M, Carrascosa A. Diabetologia; 1997 Sep 12; 40(9):1107-9. PubMed ID: 9300249 [Abstract] [Full Text] [Related]
14. An association between vascular endothelial growth factor gene promoter polymorphisms and diabetic retinopathy. Szaflik JP, Wysocki T, Kowalski M, Majsterek I, Borucka AI, Blasiak J, Szaflik J. Graefes Arch Clin Exp Ophthalmol; 2008 Jan 12; 246(1):39-43. PubMed ID: 17849138 [Abstract] [Full Text] [Related]
15. Correlation of Aqueous, Vitreous, and Plasma Cytokine Levels in Patients With Proliferative Diabetic Retinopathy. Wu F, Phone A, Lamy R, Ma D, Laotaweerungsawat S, Chen Y, Zhao T, Ma W, Zhang F, Psaras C, Stewart JM. Invest Ophthalmol Vis Sci; 2020 Feb 07; 61(2):26. PubMed ID: 32084272 [Abstract] [Full Text] [Related]